Citations

Showing 10 of 108162 citations.

RNA-Seq Based Immunoglobulin Repertoire Analysis of Normal Plasma Cells Generated in an in Vitro B Cell Differentiation System
Tschumper, Renee C. , Osborne, Collin A., Chanana, Pritha , Walters, Denise K., Jelinek, Diane F., Davila, Jaime , Hoelzinger, Dominique B.

Mayo Clinic

Blood | November 14, 2019 | Volume: 134 | Issue: Supplement_1 | Pages: 1051-1051

10.1182/blood-2019-127327 Get It

Antibody secreting plasma cells (PCs) play an important role in effective humoral immune responses. The low frequency of bone marrow PCs in humans makes it challenging to obtain sufficient numbers of PCs for biologic studies. Previous studies have employed in vitro model systems to generate cells that morphologically, phenotypically, and functionally resemble normal polyclonal PCs. Gene expression profiles of in vitro generated PCs (IVPCs) mirror their normal counterparts, however to date extensive immunoglobulin (Ig) repertoire analysis of IVPCs is lacking. Here, we used a modified 3-step protocol to generate IVPCs and used RNA-seq to explore the transcriptome with emphasis on the Ig repertoire of plasmablasts and PCs. Total B cells were isolated from 3 normal donors and cultured with various cytokines and the B cell activators CpG ODN and CD40L. RNA was obtained from freshly isolated B cells (Day 0; D0) as well as from Day 4 (D4) plasmablasts, and Day 10 (D10) IVPCs. Morphologically, D10 cells exhibited typical PC morphology, including an eccentric nucleus and perinuclear hof. RNA-seq was performed on total RNA from all 3 donors and time points using the Standard TRuSeq v2 library prep and with paired end sequencing on the Illumina HiSeq 4000 platform. Principle component analysis of gene expression data showed that D0, D4 and D10 cells could be clearly segregated across all 3 normal donors. Of importance, transcripts previously described as distinguishing B cells from PCs were found to be differentially expressed including overexpression of CXCR5, CD19, EBF, CD83, PAX5, IRF8 in D0 B cells and overexpression of IRF4, Blimp-1, XBP1, BCMA, SLAMF7, Syndecan-1, CD38 and CD27 in IVPCs, thus validating our in vitro model for generating PCs. Furthermore, expression of cell cycle related transcripts such as CKS1, CDK1, and CCDN2 followed the pattern of low expression in resting B cells, increased expression in plasmablasts, and decreased expression in IVPCs confirming the cells are actively cycling in a manner comparable to cells in vivo. D10 IVPCs also overexpressed transcripts known to be upregulated during the unfolded protein response. As expected from Ig secreting cells, D10 IVPCs had an over-representation of Ig transcripts. At D0, resting B cells had high levels of IgD and IgM heavy chain (HC) transcripts. At D10, IgM transcripts modestly increased with Log2 fold change (FC) = 3 and as expected, IgD levels decreased significantly (Log2 FC = -2.2). IgA and IgG isotype transcripts significantly increased at D10 (Log2 FC > 6.0) with the IgG4 subtype having the greatest Log2 FC at 8.4. Next we focused on the Ig repertoire of D0, D4, and D10 cells. By aligning to known germline Ig sequences in IMGT/V-Quest (www.imgt.org) and then assembling the paired ends of D0, D4 and D10 Ig transcripts, we were able to analyze the Ig repertoire. Since the Ig HC variable (V) region is encoded by V, diversity (D) and joining (J) segments, only fragments that could be confidently determined were considered. All but 3 IGHV transcripts (IGHV3-35, IGHV3-47 and IGHV7-8) and 2 IGHD transcripts (IGHD4-4 and IGHD5-5) were found and all IGHJ segments were represented across the differentiation spectrum. In D0 cells, the number of unique VDJ combinations ranged from 643 to 863 across all 3 normal samples and increased to a range of 2524 to 2867 in D10 IVPCs. When looking at the differential expression of each VDJ combination from D0 to D10, a pairwise t-test for relative frequency showed that there was no significant change greater than 1%, suggesting the repertoire diversity was not skewed, thus proving the conditions for stimulation were not targeting any one starting B cell. Our data also allowed us to track clonal expansions during differentiation as defined by the increasing frequency of sequences with identical nucleotide sequence in the V region and CDR3 (including D and J regions). Hence, a single sequence could be tracked from D0 to D10. Of interest, in a small sampling of the total available sequences, only those B cells with a mutated IGHV region, characteristic of a memory B cell, went on to expand in this system whereas B cells with an unmutated IGHV did not. Our analysis of the Ig repertoire of IVPCs suggests this system provides a functional model to study Ig repertoire along the B cell differentiation process and further delineate the conditions that may result in a clonal expansion, a hallmark of many hematologic malignancies including multiple myeloma. Disclosures No relevant conflicts of interest to declare.
Long-term outcome of brain structure in female preterm infants: possible associations of liberal versus restrictive red blood cell transfusions
Benavides, Amanda , Conrad, Amy L. , Magnotta, Vincent A. , Bell, Edward F. , Nopoulos, Peg , Brumbaugh, Jane E. , Magnotta, Vincent A

Mayo Clinic

The Journal of Maternal-Fetal & Neonatal Medicine | November 14, 2019 | Volume: 34 | Issue: 20 | Pages: 3292-3299

10.1080/14767058.2019.1683157 | PMID 31722594 Get It

Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
Strouse, Christopher , Rutherford, Sarah C. , Smith, Brian J, Lossos, Izidore S. , Thompson, Carrie A. , Friedberg, Jonathan W. , Cohen, Jonathon B. , Chapman, Jennifer R. , McDonnell, Timothy J. , Flowers, Christopher R. , Martin, Peter , Strouse, Christopher S , Smith, Brian J, Jaye, David L. , Kahl, Brad S. , Feldman, Andrew L. , Casulo, Carla , Syrbu, Sergei , Witzig, Thomas E. , Nastoupil, Loretta J. , Larson, Melissa C. , Habermann, Thomas M. , Slager, Susan L. , Cerhan, James R. , Link, Brian K.

Mayo Clinic

Blood | November 14, 2019 | Volume: 134 | Issue: Supplement_1 | Pages: 1610-1610

10.1182/blood-2019-126068 Get It

INTRODUCTION Complete staging via bone marrow assessment is standard of practice for most newly diagnosed non-Hodgkin lymphoma (NHL) patients, though the methods and patterns of bone marrow assessment vary in clinical practice. The 2014 Lugano Classification recommends that in diffuse large B cell lymphoma (DLBCL), positron emission tomography-computed tomography (PET/CT) alone can designated advanced-stage disease in many, but not all cases. For most other NHL subtypes, obtaining bone marrow biopsy (BMB) remains recommended. We aimed to assess clinical practice patterns of marrow assessment and the performance of PET/CT in the clinical setting. METHODS The Lymphoma Epidemiology of Outcomes (LEO) cohort is a prospective cohort from 8 academic medical centers. All patients were enrolled in the cohort within 6 months of diagnosis, and prospectively followed. Patients with lymphoma enrolled in the cohort between July 2015 and June 2017 were included for study. Baseline clinical characteristics at diagnosis, whether BMB and/or PET/CT were performed, and the result of these assessments were extracted from the database. Bone marrow involvement on PET/CT was abstracted via review of radiology reports. No central review of images was utilized. RESULTS In total, 3,251 patients were included, consisting of the following subtypes: DLBCL (n=1,098), follicular lymphoma (FL n=730), mantle cell lymphoma (MCL n=302), T-cell lymphoma (TCL n=278), marginal zone lymphoma (MZL n=269), other NHL (n=505) and composite lymphoma (n=69). Other clinical characteristics are shown in table 1. Staging BMB was obtained in 78% of patients, PET/CT was obtained in 56%, both BMB and PET/CT were obtained in 46% while neither were obtained in 9% (table 1). There were significant differences in lymphoma subtype between patients having any bone marrow assessment vs no bone marrow assessment (p<0.0001). MCL (96%) and DLBCL (94%) most frequently had any bone marrow assessment, while MZL was least frequently assessed (84%). Patients undergoing any bone marrow assessment had higher median lactate dehydrogenase (247 U/L vs 206 U/L, p=0.0002). Among the 8 enrolling medical centers, the frequency of bone marrow biopsy at diagnosis ranged from 53% to 86%, and the frequency of PET/CT at diagnosis ranged from 34% to 94% (p<0.0001, table 1). Among patients with DLBCL who had positive bone marrow by either PET/CT or BMB (N=107), 41% (44/107) were positive by BMB only, 19% (20/107) were positive by PET/CT only, and 40% (43/107) were positive by both. Figure 1 shows results of similar analyses for FL, MCL, MZL, and TCL. Using BMB as a gold standard for marrow involvement, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT for marrow assessment in DLBCL is 49%, 90%, 68% and 91%, respectively. Data for other subtypes are shown in table 2. Patients undergoing both PET/CT and BMB had lower median LDH (231 U/L vs 254 U/L, p=0.0032) than those undergoing one or neither assessments. CONCLUSION Overall, 91% of all patients with newly diagnosed NHL had bone marrow assessments via either PET/CT, BMB or both. The significant variation in the frequency of BMB and PET/CT use among the 8 centers reflects a lack of clear consensus on staging practices regarding bone marrow assessment. The sensitivity of PET/CT for detection of marrow involvement was less than 50% across all subtypes. It is possible the sensitivity of PET/CT could be improved via a centralized review process of the images, as is performed in some clinical trials, however practical approaches for implementing such reviews in clinical practice have not been developed. Between 92-100% of all positive bone marrows were detected by BMB, except in cases with DLBCL in which 19% of positive bone marrows were missed by BMB but detected by PET/CT. Thus, in our analysis, BMB more reliably captured marrow involvement that PET/CT in all subtypes in which both assessments were performed. However, neither PET/CT nor BMB alone were able to identify all cases of bone marrow involvement and use of both modalities may be necessary in cases where marrow involvement would have clinically important implications. Disclosures Rutherford: Juno Therapeutics Inc: Consultancy, Honoraria; Janssen Scientific Affairs: Consultancy, Honoraria; Seattle Genetics: Consultancy, Honoraria; Verastem: Consultancy, Honoraria; Karyopharm: Honoraria, Membership on an entity's Board of Directors or advisory committees; AstraZeneca: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Heron: Consultancy, Honoraria. Kahl:ADC Therapeutics: Consultancy, Research Funding; Seattle Genetics: Consultancy; TG Therapeutics: Consultancy; BeiGene: Consultancy. Lossos:Janssen Scientific: Membership on an entity's Board of Directors or advisory committees; NIH: Research Funding; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees. Friedberg:Acerta: Other: Data & Safety Monitoring Committee; Bayer: Honoraria, Other: Data & Safety Monitoring Committee. Casulo:Celgene: Research Funding; Roche: Other: Travel, accommodation, expenses; Gilead: Honoraria, Other: Travel, accommodation, expenses. Cohen:Astra Zeneca: Research Funding; Takeda Pharmaceuticals North America, Inc.: Research Funding; Hutchison: Research Funding; Gilead/Kite: Consultancy; Bristol-Meyers Squibb Company: Research Funding; LAM Therapeutics: Research Funding; UNUM: Research Funding; Lymphoma Research Foundation: Research Funding; ASH: Research Funding; Seattle Genetics, Inc.: Consultancy, Research Funding; Janssen Pharmaceuticals: Consultancy; Genentech, Inc.: Consultancy, Research Funding. Nastoupil:TG Therapeutics: Honoraria, Research Funding; Novartis: Honoraria; Spectrum: Honoraria; Celgene: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Genentech, Inc.: Honoraria, Research Funding; Gilead: Honoraria; Bayer: Honoraria. Flowers:Denovo Biopharma: Consultancy; Spectrum: Consultancy; National Cancer Institute: Research Funding; Optimum Rx: Consultancy; Burroughs Wellcome Fund: Research Funding; Acerta: Research Funding; Bayer: Consultancy; BeiGene: Consultancy, Research Funding; Eastern Cooperative Oncology Group: Research Funding; TG Therapeutics: Research Funding; Genentech, Inc./F. Hoffmann-La Roche Ltd: Consultancy, Research Funding; Gilead: Consultancy, Research Funding; Karyopharm: Consultancy; AstraZeneca: Consultancy; Pharmacyclics/Janssen: Consultancy, Research Funding; AbbVie: Consultancy, Research Funding; V Foundation: Research Funding; Millenium/Takeda: Research Funding; Celgene: Consultancy, Research Funding. Cerhan:Janssen: Membership on an entity's Board of Directors or advisory committees; Celgene: Research Funding; NanoString: Research Funding. Martin:Sandoz: Consultancy; Karyopharm: Consultancy; Celgene: Consultancy; Teneobio: Consultancy; I-MAB: Consultancy; Janssen: Consultancy.
Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients
Savedra, Michelle E., Szuberski, Jessica, Porter, Tavanna R. , Hein, Molly S., Nguyen, Phuong L., Rangan, Aruna , Hoyer, James D., Oliveira, Jennifer L. , Shi, Min

Mayo Clinic

Blood | November 14, 2019 | Volume: 134 | Issue: Supplement_1 | Pages: 1011-1011

10.1182/blood-2019-131125 Get It

Background: Voxelotor (GBT440) is a small molecule allosteric effector with high specificity for hemoglobin (Hb) that inhibits Hb S polymerization by increasing hemoglobin oxygen affinity. Developed as an oral, once-daily medication, it is undergoing phase 3 randomized clinical trials in sickle cell disease patients. Therapeutic monitoring of Hb quantitative fractions is routine in sickle cell disease patients to assess medication and transfusion effects and future treatment requirements. In the clinical laboratory, some therapies can alter the Hb fraction percentages or characteristic protein migration/elution patterns and can mimic complex hemoglobinopathy disorders causing misinterpretation or unnecessary additional testing. We present the effects of voxelotor on hemoglobin identification/monitoring testing in multiple testing platforms. Methods: A whole blood anticoagulated sample from a male patient who was undergoing treatment for sickle cell disease was received for routine hemoglobin testing. Five additional samples with similar features were also received from three male patients (age range of all patients was 18 to 22 years) with sickle cell disease. Hemoglobin protein analysis was performed using standard methods including cation-exchange high performance liquid chromatography (HPLC), capillary electrophoresis (CE), isoelectric focusing (IEF), intact globin chain mass spectrometry (MS), sickle solubility and hemoglobin stability studies. DNA sequencing of the alpha (HBA1/HBA2) and beta globin (HBB) genes was performed on one sample. Results: CE (initial and 50:50 mix, figures 1A and 1B, respectively) revealed a Hb S peak with a shoulder and additional small peaks at position 203 (D zone) and 234 (cusp of zones E/A2). In some cases the 234 peak interfered with instrument designation of the A2 peak (50:50 mix with normal) and shifted the Hb S peak into the E zone which risks variant misidentification (figure 1C). Our laboratory overcame this limitation by substituting the normal sample with beta thalassemia trait to enhance the Hb A2 peak after mixing. HPLC tracings (figure 1D) showed a duplex peak pattern in the D and S windows with separate peak quantification percentages (index case showed elution at 4.18 and 4.37 minutes with 14.9% and 66.4%, respectively). The dual peaks detected by HPLC partially mimicked compound Hb S/D-Punjab. IEF (figure 1E) showed additional bands at -4.7, and -11.5 (Schneider-Barwick ratios). The additional peaks identified by CE and IEF mimicked an alpha chain hemoglobin variant; however, the expected hybrid patterns were atypical prompting further investigation. Sickle solubility was positive, heat stability studies were negative and mass spectrometry did not definitively detect abnormal peaks other than βS. DNA sequencing of the alpha and beta globin genes did not reveal abnormalities other than homozygous Hb S. Similar hemoglobin patterns were identified in all samples tested. Conclusion: Voxelotor treatment in sickle cell patients results in a distinctive pattern alteration in hemoglobin testing. Methods may not give accurate variant percentage estimation and the treatment may result in shifts in variant mobility causing erroneous laboratory results. Novel therapies are increasing in the treatment of hemoglobin disorders and medication effect should be a consideration when atypical patterns are encountered in the laboratory. Knowledge of these artifacts by clinicians and laboratorians is paramount to avoid erroneous diagnosis, unnecessary additional testing and inaccurate Hb variant quantitation for monitoring purposes. Notification of current treatment regimens to testing facilities is highly recommended in these patients. Figure 1 Disclosures No relevant conflicts of interest to declare.
Optical coherence elastography for evaluating Rayleigh wave propagation in soft matter-micellar fluids
Liu, Hsiao‐Chuan , Kijanka, Piotr , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 14, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 3032-3032

10.1121/1.5137511 Get It

Wormlike micellar (WM) fluids exhibit a self-assembly property and viscoelastic behavior which make them a promising material for representing biological fluids, ultrasoft tissue phantoms and drug delivery carriers. Although WM biochemistry has been investigated, the mechanical properties have been rarely discussed because of the complexity of soft matter systems. Here, we demonstrate that optical coherence elastography (OCE) is capable of measuring Rayleigh wave of micellar fluids. Three solutions with concentrations of 100, 200, 300 and 400 mM, were considered in the study. Ultrasound excitation to produce Rayleigh waves was accomplished using 7.5 MHz burst excitation signals of length 4.0 ms repeated at a rate of 19 Hz. The optical coherence tomography (OCT) acquisition was set to 50 lateral positions and 4000 A-scans for each lateral position at a 76 kHz scan rate for total acquisition time of 52.6 ms. Ultrasound-based shear wave elastography, implemented on a Verasonics system, was used to obtain group and phase velocity of the shear wave in all micellar fluids as reference. Our research results demonstrated that Rayleigh wave in micellar fluids can be evaluated by OCE and mechanical properties like Young’s modulus can be assessed. A wide of concentration ranges of WM fluids would provide a more realistic model to mimic biological fluids and tissues.
Quantitative assessment of surface wave in kidney using optical coherence elastography
Liu, Hsiao‐Chuan , Kijanka, Piotr , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 14, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 3032-3032

10.1121/1.5137513 Get It

Patients with chronic kidney disease (CKD) and renal transplant rejection are at high risk to develop advanced pathology including glomerular sclerosis and renal interstitial fibrosis. The elasticity of kidney tissues is associated with the disease progression and can be evaluated with ultrasound elastography. Understanding how tissue pathology changes the renal mechanical properties is crucial. Optical coherence elastography (OCE) might be a promising tool for evaluating renal tissues due to higher resolution. A phantom with 8% gelatin and 2% cellulose (50 mm) was fabricated to validate the ability of OCE to bulk materials and the results were confirmed by comparing the dataset obtained with an ultrasound-based Verasonics system as the ground truth. Excitation signals, composed with 4 cycles of a 400 Hz harmonic wave repeated at a rate of 38 Hz, were directly applied to the surface area with two directions and cortical regions of ex vivo porcine kidneys that had been cut open. Preliminary results showed that the velocity of surface wave on the cortical regions was near 1 m/s and corresponded with the result of shear waves from Verasonics system (1.2 m/s). Our study demonstrated that OCE has an ability to assess the mechanical properties of bulk materials and is a promising tool to evaluate mechanical properties of renal tissue with high resolution and sensitivity.
Evaluating robustness of local phase velocity imaging in elastic and viscoelastic phantoms
Wood, Benjamin , Kijanka, Piotr , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 14, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 3032-3032

10.1121/1.5137514 Get It

Local Phase Velocity Imaging (LPVI) is a novel method of shear wave elastography (SWE) analysis, which provides phase velocity images at multiple frequencies. The primary components of this method include using two acoustic radiation force (ARF) pushes near the edges of the field-of-view. Fourier analysis of the spatiotemporal data is conducted to obtain maps of the phase velocity at multiple frequencies. A robustness study was conducted to evaluate the effectiveness of LPVI in elastic and viscoelastic phantoms with different mechanical properties, ARF focal depths and F-numbers, and shear wave frequencies using a linear array transducer. The results showed effective phase velocity reconstructions for most scanning parameters in the phantoms evaluated. We evaluated mean and standard deviations of phase velocities in the different phantoms for regions-of-interest defined in the images. Issues were seen with shear wave signal being distorted from the incident push when using low F-numbers as well as issues with attenuating shear waves with higher F-numbers and deeper focal depths. Future directions of this work will be to evaluate the robustness of LPVI in inclusion phantoms as well as testing on a curved array transducer.
Shear wave attenuation measurement of tissue-mimicking materials using a two-point frequency shift method
Kijanka, Piotr , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 14, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 3071-3071

10.1121/1.5137656 Get It

Shear wave elastography (SWE) is a method used in several clinical applications for assessment of soft tissue viscoelastic properties. SWE uses an acoustic radiation force (ARF) to produce laterally propagating shear waves to obtain the wave velocity. Here, we present a two-point shear wave attenuation coefficient measurement method without using a rheological model. The technique uses information related to the magnitude spectrum frequency shift of shear waves measured at only two lateral locations. We examined how the distance from the start of the ARF push and the distance between the two locations affected the attenuation coefficient estimates. We tested this method on digital phantom data created using local interaction simulation approach in viscoelastic media and on data acquired from phantom and ex vivo liver experiments. We compared the results from the two-point method with other two techniques used for assessing shear wave attenuation: the frequency-shift-based (FS) method and attenuation measuring ultrasound shearwave elastography. In comparison with the FS method, our technique does not assume that the shape parameter of the Gamma function is constant over a lateral distance. Tests conducted showed that the proposed method is feasible to provide robust attenuation estimates based on two measurement points in tissue-mimicking materials and ex vivo liver tissue.
Evaluation of optoacoustic response with a combined Monte Carlo optical and acoustic simulation approach
Rose, James A., Buhrow, Benjamin , Haider, Clifton R. , Urban, Matthew W. , Rose, James A.

Mayo Clinic

The Journal of the Acoustical Society of America | November 13, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 2756-2756

10.1121/1.5136543 Get It

Optoacoustic, or photoacoustic, imaging combines the penetration capabilities of ultrasound imaging with the contrast mechanism of optical absorption related to the photoacoustic effect. To enable modeling of photoacoustic measurements and imaging applications, the problem can be divided into modeling of the optical photon propagation and the resulting acoustic wave propagation. In highly scattering media such as soft tissues, Monte Carlo (MC) methods are used to evaluate photon propagation, absorption and the subsequent generation of a heat source that produces the photoacoustic effect. Acoustic wave equations are then used to model the propagation of the sound in the medium. However, if the appropriate physics could be modeled with a single tool, there would be advantages of consistency in spatial and temporal domains as well as easier integration of the optical and acoustic simulations. We propose using MC methods for optical photon propagation and for the acoustic wave propagation. The simulations are split into two stages for the optical photon propagation and the acoustic phonon propagation. We describe how the same MC framework is used to model photon propagation and acoustic phonon propagation. We will then demonstrate this new combined MC framework in models of photoacoustic problems in homogeneous and heterogeneous cases. These results will be compared with results from using k-Wave models for the acoustic wave propagation. The correspondence between k-Wave the acoustic MC model are shown to be in good agreement.
Ultrasonic evaluation of bone health in patients
Fatemi, Mostafa , Alizad, Azra

Mayo Clinic

The Journal of the Acoustical Society of America | November 13, 2019 | Volume: 146 | Issue: 4_Supplement | Pages: 2863-2863

10.1121/1.5136934 Get It

Noninvasive and quantitative methods for evaluation of bone health are of interest in clinical practice. Two areas of particular interest include evaluation of bone fracture healing and assessment of osteoporosis. Determination of bone healing time impacts patient health and the associated economic factors. Furthermore, assessment of bone quality in patients at risk for osteoporosis/osteopenia can benefit a large number of patients in the upper age group. Here, we present a quantitative method for the evaluation of bone integrity and quality. This method is based on analyzing the acoustic response of bone to stimulation provided by the acoustic radiation force of ultrasound. Longitudinal studies for bone healing assessment were conducted on a group of patients with clavicle fracture. The contralateral intact bone was used as a control for each patient. Bone healing assessments were performed using mode decomposition. It was found that the healing process could be detected in 80% of fractured bones. A separate study was conducted to differentiate osteoporotic/osteopenic from normal bones. A total of 27 adult volunteers in two groups of healthy and those with osteopenia/osteoporosis were tested. Results of the test on tibia showed that osteoporosis/osteopenia bones could be differentiated from the healthy ones (&lt;2 × 10-5).